Yes—absolutely.In fact, regulatory strategy is most powerful before a physical prototype exists. At the earliest stage, regulatory thinking acts as a design compass. It tells you what you can build, how risky it will be, and what proof you’ll eventually need—before you spend real money on engineering. How Regulatory Strategy Works at the “Paper Stage” […]
Author: admin
What Breaks When Regulatory Strategy Starts Too Late
When regulatory strategy starts after prototyping, things don’t just slow down—they break. And once they break, they are expensive to fix. Medical device development is not linear. FDA expectations are woven into design, testing, and evidence generation. When those expectations are ignored early, downstream failures stack up fast. What Actually Goes Wrong (and Why It […]
When Should Regulatory Strategy Actually Start for a Medical Device?
Direct answer: regulatory strategy should start at the idea stage, not after you build a prototype. If you wait until the device is engineered to think about FDA requirements, you’ve already made decisions that may be expensive—or impossible—to fix later. Why Regulatory Strategy Starts at Ideation From the very beginning, the U.S. Food and Drug […]
Why Speed Is the Enemy of Good Fixes
How rushing to close issues creates shallow solutions—and repeat failures Speed is often praised in regulated environments. Fast responses look decisive. Quick closures look efficient. Leaders feel reassured when issues disappear from dashboards. But here’s the uncomfortable reality: the faster you rush to close an issue, the more likely it is to come back. In […]
Why the Same Problems Keep Showing Up in Medical Device Development
(And What Regulators Are Actually Looking For) The Everyday Problem A safety issue shows up during testing.The team investigates, applies a fix, and documents the decision. Everyone moves on. Months later, a similar issue appears.Sometimes it’s the exact same problem. Sometimes it looks new—but it feels familiar. Now the question comes up: Why are we […]
Why Fixes That Look Good on Paper Fail in Practice
Paper compliance isn’t the same as real-world performance On paper, everything can look perfect. The testing plan is written.The documentation is complete.The boxes are checked.The audit trail is clean. And yet—things still go wrong. This is one of the most common (and expensive) traps in regulated work: confusing paper compliance with real-world effectiveness. The problem […]
The False Comfort of Checking the Box
Why activity feels good—but doesn’t always fix anything Why “doing something” feels like progress Checking a box feels productive.You sent the email.You updated the SOP.You held the training.You documented the CAPA. It feels like the problem is handled. But here’s the hard truth: activity is not the same as impact. In regulated environments, it’s easy […]
The danger of “just reminding people”
Why telling people to “be careful” doesn’t fix real problems When something goes wrong and the fix is “just remind people”, that’s not a solution. That’s a warning sign.In real life—busy labs, fast-moving studies, tight timelines—people don’t fail because they don’t care. They fail because systems are built to depend on memory, and memory is […]
When Should Regulatory Strategy Start for a Medical Device?
Regulatory strategy should start the moment you decide to build a medical device—before you lock the intended use, user, setting, claims, or design inputs. Those early choices determine FDA pathway, evidence burden, testing scope, quality system requirements, and clinical risk. If you start later, you don’t “add regulatory”; you inherit avoidable cost, delay, and valuation […]